News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
222,066 Results
Type
Article (7066)
Company Profile (17)
Press Release (214983)
Section
Business (63117)
Career Advice (294)
Deals (14764)
Drug Delivery (25)
Drug Development (36748)
Employer Resources (24)
FDA (6396)
Job Trends (4905)
News (121742)
Policy (11612)
Tag
Academia (561)
Alliances (14638)
Alzheimer's disease (545)
Approvals (6376)
Artificial intelligence (53)
Bankruptcy (144)
Best Places to Work (4549)
Breast cancer (46)
Cancer (554)
Cardiovascular disease (42)
Career advice (257)
CAR-T (37)
Cell therapy (115)
Clinical research (30183)
Collaboration (142)
COVID-19 (696)
C-suite (38)
Data (699)
Diabetes (60)
Diagnostics (2140)
Drug pricing (33)
Earnings (32418)
Events (29990)
Executive appointments (105)
FDA (6678)
Funding (121)
Gene therapy (77)
GLP-1 (138)
Government (1239)
Healthcare (6113)
Infectious disease (732)
Inflammatory bowel disease (47)
Interviews (45)
IPO (7913)
Job creations (570)
Job search strategy (220)
Layoffs (35)
Legal (2082)
Liver cancer (35)
Lung cancer (76)
Manufacturing (54)
Medical device (4511)
Medtech (4512)
Mergers & acquisitions (6938)
Metabolic disorders (155)
Neuroscience (646)
NextGen Class of 2024 (1498)
Non-profit (709)
Northern California (729)
Obesity (87)
Opinion (65)
Patents (58)
People (14196)
Phase I (9569)
Phase II (13292)
Phase III (9984)
Pipeline (318)
Postmarket research (796)
Preclinical (3493)
Radiopharmaceuticals (115)
Rare diseases (91)
Real estate (997)
Regulatory (8795)
Research institute (508)
Resumes & cover letters (39)
Southern California (618)
Startups (676)
United States (6069)
Vaccines (116)
Weight loss (57)
Date
Today (61)
Last 7 days (391)
Last 30 days (1952)
Last 365 days (17086)
2024 (15628)
2023 (19103)
2022 (22250)
2021 (23640)
2020 (21803)
2019 (14445)
2018 (10641)
2017 (11457)
2016 (9547)
2015 (11740)
2014 (8103)
2013 (5878)
2012 (6043)
2011 (6749)
2010 (6218)
Location
Africa (174)
Arizona (34)
Asia (17214)
Australia (4760)
California (1564)
Canada (728)
China (107)
Colorado (57)
Connecticut (86)
Europe (27242)
Florida (215)
Georgia (34)
Illinois (111)
Indiana (77)
Japan (39)
Maryland (205)
Massachusetts (1162)
Minnesota (60)
New Jersey (568)
New York (511)
North Carolina (281)
Northern California (729)
Ohio (42)
Pennsylvania (416)
South America (299)
Southern California (618)
Texas (222)
Utah (34)
Virginia (35)
Washington State (248)
222,066 Results for "immunocore limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immunocore to present at upcoming November 2024 investor conferences
November 11, 2024
·
1 min read
BioCapital
Immunocore to present at the Jefferies Global Healthcare Conference
Immunocore Holdings plc today announced that management will participate in the Jefferies Global Healthcare Conference.
May 30, 2024
·
6 min read
Press Releases
Immunocore reports third quarter financial results and provides a business update
November 6, 2024
·
25 min read
Business
Immunocore to present at the 2024 Cantor Global Healthcare Conference
September 12, 2024
·
1 min read
Business
Immunocore announces transition of Chief Financial Officer
August 29, 2024
·
6 min read
Drug Development
Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous melanoma
Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”) today announces randomization of the first patient in the PRISM-MEL-301 trial, assessing the efficacy and safety of brenetafusp (IMC-F106C; PRAME-A02), in combination with nivolumab, in first-line advanced or metastatic cutaneous melanoma.
June 18, 2024
·
10 min read
BioCapital
Immunocore presented two posters at CROI 2024
Immunocore Holdings plc presented two posters at the 2024 Conference on Retroviruses and Opportunistic Infections.
March 5, 2024
·
2 min read
BioCapital
Immunocore to present at upcoming April 2024 investor conferences
Immunocore Holdings plc, a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, announced that management will participate in the following investor conferences in April.
April 4, 2024
·
1 min read
BioCapital
Immunocore announces upcoming presentation and posters at ASCO 2024
Immunocore Holdings plc will present Phase 1 expansion data for brenetafusp, the first off-the-shelf ImmTAC therapy targeting PRAME, in patients with late-line cutaneous melanoma, all previously treated with anti-PD1 and the vast majority having received ipilimumab, at the 2024 American Society of Oncology Annual Meeting commencing on 31 May.
April 24, 2024
·
10 min read
BioCapital
Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response
Immunocore Holdings plc presented three posters about KIMMTRAK® for the treatment of patients with unresectable or metastatic uveal melanoma at the 2024 ASCO Annual Meeting.
June 1, 2024
·
10 min read
1 of 22,207
Next
